Clinical Evaluation of Hair Removal and Permanent Hair Reduction for Skin Types VI Using Intense Pulsed Light
NCT ID: NCT02452398
Last Updated: 2020-11-03
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
79 participants
INTERVENTIONAL
2015-01-31
2017-04-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Each subject will receive six treatments at four to six week intervals upon re-growth of hair and return for follow-up visits at one, three and six months after the last treatment.
Measurement Equipment Standard High Resolution Digital Camera
Labels for hair count Customized hair count sticker templates will be placed directly on the skin and the hairs in this window will be counted at specific visits during the study as detailed in section.
Study Procedures Each subject will participate in the study for a period of at least 11 months. The study is anticipated to be completed within twelve months.
Test spots Up to 3 test spots will be performed in the selected treatment area to determine the optimal parameters / setting.
Treatment
The treatment areas are divided into 3 groups. Each Subjects will be allocated to one of the following groups::
* Two small anatomical areas (right and left axillae and double sided bikini line) or;
* One double sided large area (right and left thighs) or;
* One large area (whole back / abdomen)
Based on the mild nature of treatment, anesthesia is not required. Before starting treatment apply a layer of conductive gel to the treatment area.
After applying the conductive gel, locate the applicator in close contact, perpendicular to the skin with no pressure applied. Pressing the applicator will fire the IPL pulse. In order to ensure full coverage of the treatment area applicator placement should overlap approximately 1/3 of the previously treated skin.
Post-treatment Instructions Cold packs may be placed on the treated area for post treatment cooling. Subjects should be aware that post treatment erythema, edema and some discomfort of the treated areas are possible and should not be a cause for concern. They may also experience some purpura in the treated areas which would be expected to resolve within several days.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment Group
Hair removal treatment using Venus Versa IPL energy
Treatment group
The intense pulsed light (IPL) applicator with a wavelength of 690 nm and spot size (treatment area) of 30 mm by 10 mm will be used to deliver the energy to the treatment area.
No intervention
Subject will act as their own control where the baseline hair count will be used as a comparator to the hair count after treatment.
No intervention
Subject hair count at baseline will act as the control to which the hair count at 6 months after the last treatment.
No intervention
Subject will act as their own control where the baseline hair count will be used as a comparator to the hair count after treatment.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Treatment group
The intense pulsed light (IPL) applicator with a wavelength of 690 nm and spot size (treatment area) of 30 mm by 10 mm will be used to deliver the energy to the treatment area.
No intervention
Subject will act as their own control where the baseline hair count will be used as a comparator to the hair count after treatment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Subject has black or dark brown terminal hairs in the areas to be treated.
3. Terminal hair density requirement of greater than 15 hairs within the hair count site (3x3 cm area) as determined by manual hair count performed by the study investigator.
4. Healthy adult, male or female, 21 years of age or older with skin type V-VI;
5. Having a suitable treatment area for hair removal;
6. Able and willing to comply with the treatment/follow-up schedule and requirements;
7. Women of child-bearing potential (women who have not had a hysterectomy, bilateral oophorectomy or are not postmenopausal) are required to be using a reliable method of birth control at least three months prior to enrollment and throughout the course of the study.
Exclusion Criteria
2. Pregnant, expectation of pregnancy, postpartum or nursing (\<6 months);
3. Hormonal disorders that may affect hair growth;
4. Immunosuppressive diseases, including AIDS and HIV infection, or use of immunosuppressive medications;
5. Livedo reticularis;
6. Uncontrolled systemic diseases such as diabetes;
7. Active infections in the treated area;
8. Dysplastic nevi;
9. Significant concurrent skin conditions or any inflammatory skin conditions;
10. Active cold sores, open lacerations or abrasions;
11. Chronic or cutaneous viral, fungal, or bacterial diseases;
12. Current cancer;
13. History of skin cancer or pre-cancerous lesions at the treatment areas;
14. Use of Accutane™ (Isotretinoin) within the past six month;
15. Keloid or Hypertrophic scar formation in the treatment area;
16. Tattoos in the treatment area;
17. Bleeding coagulopathies or use of anticoagulants;
18. Auto-immune disorders;
19. Erythema abigne, when identified treatments should be discontinued;
20. Photosensitivity disorder that can be exacerbated by laser or intense light;
21. Herpes simplex in the treatment area;
22. Use of medications, herbal supplements, perfumes or cosmetics that may affect sensitivity to light;
23. Poor wound healing;
24. Sunburns;
25. Unable or unlikely to refrain from artificial tanning, including the use of tanning booths, prior (at least a month) and during the course of the evaluation;
26. Prior skin treatment with laser or other devices on the same treated areas within the last six months prior to study enrollment or during the course of the study.
21 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Venus Concept
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tracey L Mancuso
Role: STUDY_DIRECTOR
Venus Concept
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dermatology and Laser Centre
Manhattan Beach, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CS0115
Identifier Type: -
Identifier Source: org_study_id